# Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.

> **NCT05534334** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 30 (estimated)

## Conditions studied

- Oral Pyogenic Granuloma

## Interventions

- **DRUG:** Solu-Cortef

## Key facts

- **NCT ID:** NCT05534334
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-11-29
- **Final completion:** 2022-11-29
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05534334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05534334, "Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05534334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*